PL, A., C, C., ML, C., & MA, M. (2025). Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment. Journal of acquired immune deficiency syndromes (1999), 100(2), 162. https://doi.org/10.1097/QAI.0000000000003715
Chicago Style (17th ed.) CitationPL, Anderson, Coppinger C, Cottrell ML, and Marzinke MA. "Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment." Journal of Acquired Immune Deficiency Syndromes (1999) 100, no. 2 (2025): 162. https://doi.org/10.1097/QAI.0000000000003715.
MLA (9th ed.) CitationPL, Anderson, et al. "Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment." Journal of Acquired Immune Deficiency Syndromes (1999), vol. 100, no. 2, 2025, p. 162, https://doi.org/10.1097/QAI.0000000000003715.